Circ_0075825 promotes GC progression via sponging miR-432-5p to regulate SOX9 expression level, and it may be a novel therapeutic target for treating GC.
Circ_0075825 promotes gastric cancer progression via adsorbing miR-432-5p to modulate SOX9.